ATE199318T1 - Dopaminreinkorporationshemmer zur behandlung des parkinsonschen syndroms - Google Patents

Dopaminreinkorporationshemmer zur behandlung des parkinsonschen syndroms

Info

Publication number
ATE199318T1
ATE199318T1 AT94914579T AT94914579T ATE199318T1 AT E199318 T1 ATE199318 T1 AT E199318T1 AT 94914579 T AT94914579 T AT 94914579T AT 94914579 T AT94914579 T AT 94914579T AT E199318 T1 ATE199318 T1 AT E199318T1
Authority
AT
Austria
Prior art keywords
syndrome
parkinson
hydrogen
reincorporation
acyl
Prior art date
Application number
AT94914579T
Other languages
English (en)
Inventor
Takayuki Namiki
Toshihiro Morimoto
Kenichi Kishii
Nobuyuki Kawakatsu
Makoto Kimura
Kyoko Yamasaki
Mariko Onoda
Yuji Yoshiko
Kazunori Harada
Masayuki Yanagi
Takeshi Yamamoto
Masato Inazu
Masaki Mitani
Original Assignee
Pola Chem Ind Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pola Chem Ind Inc filed Critical Pola Chem Ind Inc
Application granted granted Critical
Publication of ATE199318T1 publication Critical patent/ATE199318T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Finger-Pressure Massage (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Eye Examination Apparatus (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT94914579T 1993-06-25 1994-04-28 Dopaminreinkorporationshemmer zur behandlung des parkinsonschen syndroms ATE199318T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP15556493 1993-06-25
PCT/JP1994/000728 WO1995000149A1 (fr) 1993-06-25 1994-04-28 Inhibiteur de reincorporation de dopamine

Publications (1)

Publication Number Publication Date
ATE199318T1 true ATE199318T1 (de) 2001-03-15

Family

ID=15608814

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94914579T ATE199318T1 (de) 1993-06-25 1994-04-28 Dopaminreinkorporationshemmer zur behandlung des parkinsonschen syndroms

Country Status (13)

Country Link
US (1) US5747493A (de)
EP (1) EP0706796B1 (de)
JP (1) JP3062249B2 (de)
KR (1) KR100307660B1 (de)
AT (1) ATE199318T1 (de)
AU (1) AU674955B2 (de)
CA (1) CA2163986A1 (de)
DE (1) DE69426771T2 (de)
DK (1) DK0706796T3 (de)
ES (1) ES2157258T3 (de)
GR (1) GR3035688T3 (de)
PT (1) PT706796E (de)
WO (1) WO1995000149A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3571114B2 (ja) * 1995-07-11 2004-09-29 ポーラ化成工業株式会社 麻薬拮抗剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1545094A (en) * 1976-12-14 1979-05-02 Gist Brocades Nv Piperazine derivatives
US4469695A (en) * 1980-02-25 1984-09-04 Ayerst, Mckenna & Harrison, Inc. 2-(4-Hydroxyalkyl-1-piperazinyl)-2,4,6-cycloheptatrien-1-one derivatives
IE58370B1 (en) * 1985-04-10 1993-09-08 Lundbeck & Co As H Indole derivatives
CS271571B1 (en) * 1987-12-10 1990-10-12 Protiva Miroslav Piperazine derivatives, their salts and method of their preparation
IL90279A (en) * 1988-05-24 1995-03-30 American Home Prod History of piperazinyl carboxamide, their preparation and the pharmaceutical preparations containing them
DE68903263T2 (de) * 1988-10-10 1993-05-19 Akzo Nv Substituierte aromatische verbindungen mit zentraler nervensystem-wirkung.
DE69010232T2 (de) * 1989-03-03 1994-12-01 Dainippon Pharmaceutical Co 2-(1-Piperazinyl)-4-phenylcycloalkanpyridin-Derivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten.
JPH0747574B2 (ja) * 1989-03-03 1995-05-24 大日本製薬株式会社 ピリジン誘導体及びそれを有効成分とする向精神剤
TW205034B (de) * 1990-09-13 1993-05-01 Pola Kasei Kogyo Kk
US5089497A (en) * 1990-09-20 1992-02-18 Warner-Lambert Company Substituted piperazines as central nervous system agents
CA2067475C (en) * 1991-05-08 2000-10-10 Yasuo Oshiro Carbostyril derivatives and their use

Also Published As

Publication number Publication date
DE69426771D1 (de) 2001-04-05
DK0706796T3 (da) 2001-03-26
WO1995000149A1 (fr) 1995-01-05
EP0706796A4 (de) 1999-03-24
DE69426771T2 (de) 2001-06-13
CA2163986A1 (en) 1995-01-05
US5747493A (en) 1998-05-05
AU6689194A (en) 1995-01-17
ES2157258T3 (es) 2001-08-16
EP0706796A1 (de) 1996-04-17
EP0706796B1 (de) 2001-02-28
KR100307660B1 (ko) 2001-12-28
KR960702310A (ko) 1996-04-27
GR3035688T3 (en) 2001-07-31
PT706796E (pt) 2001-06-29
AU674955B2 (en) 1997-01-16
JP3062249B2 (ja) 2000-07-10

Similar Documents

Publication Publication Date Title
CY1111951T1 (el) Φαινυλο-καρβοξαμιδικες ενωσεις χρησιμες για την αντιμετωπιση πονου
HK1074794A1 (en) The use of substituted cyanopyrrolidines for treating hyperlipidemia
ES2150489T3 (es) 1-amidinofenil-pirrolidonas, -piperidinonas, -azetinonas como inhibidores de la agregacion de plaquetas.
EA200000614A1 (ru) 2,3-замещенные соединения индола в качестве ингибиторов сох-2
ATE247089T1 (de) Pyridoncarbonsäurederivate oder ihre salze und diese als aktive bestandteile enthaltende medikamente
DK0453042T3 (da) Hidtil ukendte 2 9-disubstituerede 4H-pyhrido[1 2-a]pyridin-4-oner
ATE184483T1 (de) Spirooxathiolan-quinuclidin-derivat zur behandlung des sjögren-syndroms
RU94045271A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования синдрома тернера
DE69029693D1 (de) Hydantoin- oder Imidazolidintrionderivate zur Vorbeugung oder Behandlung von Niereninsuffizienz
ATE121621T1 (de) Verwendung von tetrahydrothienopyridinderivate als angiogenese-inhibitoren.
ATE245419T1 (de) Verwendung von benzofuroxanderivaten zur behandlung von angina pectoris
ATE199318T1 (de) Dopaminreinkorporationshemmer zur behandlung des parkinsonschen syndroms
NO971743L (no) Farmasöytisk sammensetning for profylakse og behandling av type I allergiske sykdommer
DK1174131T3 (da) Anvendelse af et middel til forbedring af astrocytfunktion til behandling af Parkinsons sygdom
MY122570A (en) Benzamide derivatives and drugs containing the same
ES2168119T3 (es) Derivados de quinoxalina para el tratamiento de tinnitus.
ATE95697T1 (de) Uricosuretische zusammensetzung.
BR9206978A (pt) Composição farmacêutica para inibir infecção com vírus da aids

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee